These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35625319)

  • 21. Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against
    Everaert A; Coenye T
    Antimicrob Resist Infect Control; 2016; 5():44. PubMed ID: 27895902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of
    Chatwin CL; Hamrick JC; Trout REL; Myers CL; Cusick SM; Weiss WJ; Pulse ME; Xerri L; Burns CJ; Moeck G; Daigle DM; John K; Uehara T; Pevear DC
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0055221. PubMed ID: 34001510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix-assisted laser desorption/ionization time-of-flight MS for the accurate identification of
    Wong KSK; Dhaliwal S; Bilawka J; Srigley JA; Champagne S; Romney MG; Tilley P; Sadarangani M; Zlosnik JEA; Chilvers MA
    J Med Microbiol; 2020 Aug; 69(8):1105-1113. PubMed ID: 32597748
    [No Abstract]   [Full Text] [Related]  

  • 25. Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases.
    Degrossi JJ; Merino C; Isasmendi AM; Ibarra LM; Collins C; Bo NE; Papalia M; Fernandez JS; Hernandez CM; Papp-Wallace KM; Bonomo RA; Vazquez MS; Power P; Ramirez MS
    Curr Microbiol; 2019 Apr; 76(4):485-494. PubMed ID: 30783798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety, Pharmacokinetics, and Food Effect of Tebipenem Pivoxil Hydrobromide after Single and Multiple Ascending Oral Doses in Healthy Adult Subjects.
    Eckburg PB; Jain A; Walpole S; Moore G; Utley L; Manyak E; Dane A; Melnick D
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of ETX0462 toward Some
    Zeiser ET; Becka SA; LiPuma JJ; Papp-Wallace KM
    Antimicrob Agents Chemother; 2023 Jan; 67(1):e0135222. PubMed ID: 36507667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
    Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS
    Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator.
    Trépanier S; Prince A; Huletsky A
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2399-405. PubMed ID: 9371340
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Mazer DM; Young C; Kalikin LM; Spilker T; LiPuma JJ
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the Interplay of Resistance Nodulation Division Efflux Pumps,
    Gautam V; Kumar S; Patil PP; Meletiadis J; Patil PB; Mouton JW; Sharma M; Daswal A; Singhal L; Ray P; Singh M
    Microb Drug Resist; 2020 Oct; 26(10):1144-1152. PubMed ID: 32354297
    [No Abstract]   [Full Text] [Related]  

  • 33. Species-specific PCR as a tool for the identification of Burkholderia gladioli.
    Whitby PW; Pope LC; Carter KB; LiPuma JJ; Stull TL
    J Clin Microbiol; 2000 Jan; 38(1):282-5. PubMed ID: 10618102
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Stewart AG; Cottrell K; Henderson A; Vemuri K; Bauer MJ; Paterson DL; Harris PNA
    Microbiol Spectr; 2021 Sep; 9(1):e0022621. PubMed ID: 34232101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from Mycobacterium tuberculosis.
    Hazra S; Xu H; Blanchard JS
    Biochemistry; 2014 Jun; 53(22):3671-8. PubMed ID: 24846409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial activity of tebipenem against various clinical isolates from various specimen, mainly urinary tract].
    Muratani T; Doi K; Kobayashi T; Nakamura T; Matsumoto T
    Jpn J Antibiot; 2009 Apr; 62(2):116-26. PubMed ID: 19673353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New β-Lactam-β-Lactamase Inhibitor Combinations.
    Yahav D; Giske CG; Grāmatniece A; Abodakpi H; Tam VH; Leibovici L
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33177185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.
    Bhowmick T; Weinstein MP
    Infect Dis Ther; 2020 Dec; 9(4):757-767. PubMed ID: 33017041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.